论文信息 - First-line avelumab + axitinib in patients with advanced hepatocellular carcinoma: Results from a phase 1b trial (VEGF Liver 100). - 字舞流文

First-line avelumab + axitinib in patients with advanced hepatocellular carcinoma: Results from a phase 1b trial (VEGF Liver 100).

M. Kudo | J. Furuse | M. Kurosaki | Y. Inaba | P. Robbins | K. Motomura | Y. Sakamoto | Y. Wada | Y. Umeyama | Yosuke Fujii | Yoichi Kamei | Mana Aizawa | Junichiro Yoshimitsu